Refractory status epilepticus: New insights in presentation, treatment, and outcome

Neurological Research

Volumn 35, Issue 2, 2013, Pages 163-168

  Hocker, Sara ^a   Wijdicks, Eelco F M ^a   Rabinstein, Alejandro A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Critical care medicine; EEG; Medical complications; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; CYCLOPHOSPHAMIDE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; IMMUNOGLOBULIN; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; METHYLPREDNISOLONE; MIDAZOLAM; PHENOBARBITAL; PREDNISONE; PROPOFOL; RITUXIMAB; THIOPENTAL; VALPROIC ACID; ANESTHETIC AGENT;

ANAPHYLAXIS; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; DRUG ACCUMULATION; ELECTROSTIMULATION THERAPY; ENCEPHALITIS; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; INFECTION; KETOGENIC DIET; KIDNEY DISEASE; KIDNEY FAILURE; LARYNX SPASM; LIVER TOXICITY; LUNG DISEASE; LUNG EDEMA; MEGALOBLASTIC ANEMIA; METHEMOGLOBINEMIA; MUSCULOSKELETAL DISEASE; NEUROTOXICITY; PARALYTIC ILEUS; PROGNOSIS; PROPOFOL INFUSION SYNDROME; REFRACTORY STATUS EPILEPTICUS; SIDE EFFECT; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TACHYPHYLAXIS; TONIC CLONIC SEIZURE; CHEMICALLY INDUCED; COMA; COMPLICATION; DRUG RESISTANCE; INTENSIVE CARE; PROCEDURES; STATUS EPILEPTICUS; STUPOR;

ANESTHETICS; ANTICONVULSANTS; COMA; CRITICAL CARE; DRUG RESISTANCE; HUMANS; PROGNOSIS; STATUS EPILEPTICUS; STUPOR;

EID: 84874596247     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000128     Document Type: Article

References (34)

1. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802-2818.
2. Cooper AD, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol. 2009;66:1505-1509.
3. Rabinstein AA, Wijdicks EF. The value of EEG monitoring after cardiac arrest treated with hypothermia. Neurology. 2012;78(11):774-775.
4. DeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029-1035.
5. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43(3 Pt 1):483-488.
6. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205-210.
7. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534-539.
8. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698-1702.
9. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146-153.
10. Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251-256.
11. Hocker S, Britton JW, Mandrekar J, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. Arch Neurol. 2012;8:1-6.
12. Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res. 2010;91:111-122.
13. Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med. 1980:69:657-666.
14. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27-34.
15. Waterhouse EJ, Garnett LK, Towne AR, Morton LD, Barnes T, Ko D, et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia. 1999;40:752-758.
16. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the Evaluation and Management of Status Epilepticus. Neurocrit Care. 2012;17:3-23.
17. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37:3024-3030.
18. Storchheim F. Status epilepticus treated by magnesium sulphate, injected intravenously. JAMA. 1933;101:1313-1314.
19. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307:462-465.
20. Fisher RS, Kaplan PW, Krumholz A, Lesser RP, Rosen SA, Wolff MR. Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol. 1988;11:537-544.
21. Shorvon SD. Status epilepticus: its clinical form and treatment in children and adults. Cambridge: Cambridge University Press; 1994.
22. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9:189-97.
23. Bodenant M, Moreau C, Sejourne' C, Auvin S, Delval A, Cuisset JM, et al. Interest of the ketogenic diet in a refractory status epilepticus in adults. Rev Neurol. 2008;164:194-199.
24. Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 2010;51:1083-1085.
25. Cervenka MC, Hartman AL, Venkatesan A, Geocadin RG, Kossoff EH. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care. 2011;15(3):519-524.
26. Patwardhan RV, Dellabadia J, Jr, Rashidi M, Grier L, Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol. 2005;64:170-173.
27. O'Neill BR, Valeriano J, Synowiec A, Thielmann D, Lane C, Wilberger J. Refractory status epilepticus treated with vagal nerve stimulation: case report. Neurosurgery. 2011;69(5):E1172-E1175.
28. Valentín A, Nguyen HQ, Skupenova AM, Agirre-Arrizubieta Z, Jewell S, Mullatti N, et al. Centromedian thalamic nuclei deep brain stimulation in refractory status epilepticus. Brain Stimul. 2011;5(4):594-598.
29. Griesemer DA, Kellner CH, Beale MD, Smith GM. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology. 1997;49:1389-1392.
30. Lisanby SH, Bazil CW, Resor SR, Nobler MS, Finck DA, Sackeim HA. ECT in the treatment of status epilepticus. J ECT. 2001;17:210-215.
31. Kohrmann M, Huttner HB, Gotthardt D, Nagel S, Berger C, Schwab S. CSF-air-exchange for pharmacorefractory status epilepticus. J Neurol. 2006;253:1100-1111.
32. Ng YT, Kerrigan JF, Rekate HL. Neurosurgical treatment of status epilepticus. J Neurosurg. 2006;105(Suppl 5):378-381.
33. Lhatoo SD, Alexopoulos AV. The surgical treatment of status epilepticus. Epilepsia. 2007;48(Suppl 8):61-65.
34. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011;14:4-10.